0001721931-20-000004.txt : 20200317 0001721931-20-000004.hdr.sgml : 20200317 20200316205913 ACCESSION NUMBER: 0001721931-20-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200316 EFFECTIVENESS DATE: 20200317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Primmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001721931 IRS NUMBER: 823006157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362983 FILM NUMBER: 20719024 BUSINESS ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 858-205-2281 MAIL ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 D 1 primary_doc.xml X0708 D LIVE 0001721931 Primmune Therapeutics, Inc. c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 858-205-2281 DELAWARE None None Corporation true 2017 Charles McDermott c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director James R. Appleman c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director Todd J. Harris c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Director Paulo S. Rangel c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director Scott Morenstein c/o JLABS San Diego 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b false 2020-02-28 false true false 0 3500000 2500000 1000000 false 2 0 0 0 false Primmune Therapeutics, Inc. /s/ Paulo S. Rangel Paulo S. Rangel Chief Business Officer 2020-03-11